To further examine whether Mi-2β depletion induced an adaptive immune response in melanoma in vivo, Tyr::CreER;BRafCA;Ptenlox/lox mice were used for the anti-PD-1 antibody treatment. This evidence concerns the gene CHD4 and melanoma.